Paul Tudor Jones Edgewise Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 35,613 shares of EWTX stock, worth $990,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,613
Previous 26,410
34.85%
Holding current value
$990,041
Previous $475,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
189Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$418 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$248 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$167 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$162 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$154 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.76B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...